S
Swee Lay Thein
Researcher at National Institutes of Health
Publications - 335
Citations - 21617
Swee Lay Thein is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Fetal hemoglobin & Population. The author has an hindex of 62, co-authored 316 publications receiving 19670 citations. Previous affiliations of Swee Lay Thein include King's College & University of Oxford.
Papers
More filters
Journal ArticleDOI
Airway and alveolar nitric oxide production, lung function, and pulmonary blood flow in sickle cell disease
Alan Lunt,Alan Lunt,Na’eem Ahmed,Gerrard F. Rafferty,Moira C. Dick,David C. Rees,David C. Rees,Sue Height,Swee Lay Thein,Swee Lay Thein,Anne Greenough,Anne Greenough +11 more
TL;DR: Airway NO flux was not elevated in the SCD children nor correlated with airways obstruction, suggesting that airway obstruction, at least in someSCD children, is not due to asthma.
Journal ArticleDOI
An integrated map of human 6q22.3-q24 including a 3-Mb high-resolution BAC/PAC contig encompassing a QTL for fetal hemoglobin.
Laurence Game,James Close,Phil Stephens,John Mitchell,Steve Best,Jacques Rochette,Christine Louis-dit-Sully,John H. Riley,Chee Gee See,Phillippe Sanseau,Lyndal Kearney,Graeme Bethel,Sean Humphray,Ian Dunham,Andrew J. Mungall,Swee Lay Thein +15 more
TL;DR: A high-resolution bacterial clone contig spanning 3 Mb covering this critical region of approximately 4 Mb between the markers D6S408 and D 6S292 on chromosome 6q23 is described.
Journal ArticleDOI
Optimal disease management and health monitoring in adults with sickle cell disease.
Jo Howard,Swee Lay Thein +1 more
TL;DR: The approach to managing adults with SCD needs to reevaluate by putting a greater emphasis on multidisciplinary care while proactively considering curative options (hematopoietic stem cell transplant and gene therapy) and experimental pharmacological agents for adults withSCD of all ages before complications render the patients ineligible for these treatments.
Journal ArticleDOI
Venous thromboembolism in adults with sickle cell disease: experience of a single centre in the UK
V. van Hamel Parsons,Kate Gardner,Kate Gardner,R Patel,Swee Lay Thein,Swee Lay Thein,Swee Lay Thein +6 more
TL;DR: The incidence of VTE in the patient cohort was higher than in the non-SCD black population; patients of all SCD genotypes with VTE had significantly elevated steady-state platelet counts compared to those without; and consideration of longer VTE prophylaxis for acute hospital admissions in SCD is suggested.
Journal ArticleDOI
NLRP3 inflammasome and bruton tyrosine kinase inhibition interferes with upregulated platelet aggregation and in vitro thrombus formation in sickle cell mice.
Sebastian Vogel,Sayuri Kamimura,Taruna Arora,Meghann L. Smith,Luis E.F. Almeida,Christian A. Combs,Swee Lay Thein,Zenaide M.N. Quezado +7 more
TL;DR: Platelet aggregation and in vitro thrombus formation were upregulated in SCD mice and were inhibited when mice were subjected to pharmacological inhibition of NLRP3 and BTK.